Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00239707 · ClinicalTrials.gov registry record · Phase 1
GIP: Glucose-dependent Insulinotropic Peptide
A Phase 1 study, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- Phase 1
- Development phase
- 41
- Enrollment target
NCT00239707 is a Phase 1 study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 41 participants.
The verdict
NCT00239707, a Phase 1 study, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to test the safety of glucose-dependent insulinotropic peptide (GIP)/GIP Analog on people with Type 2 Diabetes.
Interventions
- DRUG Normal Saline
- DRUG GIP
- DRUG Modified GIP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2003-02 |
| Est. Completion | 2006-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00239707
The ClinicalTrials.gov registry entry for NCT00239707 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Normal Saline is the first listed.
NCT00239707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00239707 about?
NCT00239707 is a clinical study titled "GIP: Glucose-dependent Insulinotropic Peptide". The purpose of this study is to test the safety of glucose-dependent insulinotropic peptide (GIP)/GIP Analog on people with Type 2 Diabetes.
What is the current status of trial NCT00239707?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 41 participants. The study started on 2003-02. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00239707?
The interventions under investigation include: Normal Saline (DRUG), GIP (DRUG), Modified GIP (DRUG).
Who is sponsoring clinical trial NCT00239707?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.